Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of HL301 on Radiation Pneumonitis in Non-small Cell Lung Cancer Patients
Clinical trial NCT04632342 · UNKNOWN
Trial details
- NCT number
- NCT04632342
- Sponsor
- Hanlim Pharm. Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-01
- Primary completion
- 2022-01-01
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.